Why Clinical Trials Matter

Clinical trials play a crucial role in understanding the safety, efficacy, and therapeutic potential of psychedelics. Through rigorous scientific research, these studies provide essential data that guide policy decisions, inform medical professionals, and expand access to psychedelic-assisted therapies.

With increasing interest in the potential of psychedelics for treating conditions like PTSD, depression, and substance use disorders, clinical trials help ensure that these substances are studied in controlled environments to maximize benefits while minimizing risks.

Disclaimer: The following links are provided for educational purposes only and do not imply endorsement of any substance, activity, or treatment. Please consult medical and legal professionals before making decisions related to psychedelics.

    1. MAPS-Sponsored Clinical Trials

      Summary: The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of psychedelic research, sponsoring clinical trials on MDMA-assisted therapy for PTSD. Their research has demonstrated promising results in treating trauma-related disorders, leading to potential FDA approval in the coming years.
      Learn more: https://maps.org/research/mdma/

    2. Johns Hopkins Center for Psychedelic and Consciousness Research

      Summary: Johns Hopkins University conducts extensive studies on the effects of psychedelics on behavior, mood, cognition, and brain function. Their research explores the therapeutic applications of psilocybin for depression, addiction, and end-of-life anxiety.
      Learn more: https://hopkinspsychedelic.org/research

    3. ClinicalTrials.gov – Psychedelic-Assisted Therapy Research

      Summary: ClinicalTrials.gov is a comprehensive database of publicly and privately funded clinical studies worldwide. It includes up-to-date information on ongoing psychedelic therapy trials, covering substances like psilocybin, MDMA, LSD, and ketamine.
      Learn more: https://clinicaltrials.gov/ct2/results?cond=&term=psychedelic&cntry=&state=&city=&dist=

    • Regulatory Approval: Many clinical trials aim to secure FDA and global regulatory approval for psychedelic-assisted therapy.

    • Expanding Treatment Options: Research is paving the way for innovative mental health treatments beyond traditional pharmaceuticals.

    • Establishing Safety Protocols: Trials ensure proper dosage guidelines, risk mitigation, and long-term safety assessments.

  • Supporting clinical trials and psychedelic research can help drive the movement forward. You can:

    • Participate in a Study: If eligible, consider enrolling in a clinical trial to contribute to scientific advancements.

    • Support Research Organizations: Donate to institutions like MAPS and Johns Hopkins to fund future studies.

    • Advocate for Policy Change: Encourage legislative support for psychedelic research and therapeutic access.

The future of psychedelic medicine depends on rigorous, ethical research. Together, we can advance the field and create safe, effective treatments for those in need.